AstraZeneca CEO Soriot says drugmaker can grow without big acquisition

· seekingalpha.com

AstraZeneca CEO Pascal Soriot says company can grow without a major acquisition, citing a strong pipeline and obesity drug ambitions. Read more here.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

If you have an ad-blocker enabled you may be blocked from ...


More AI market news · Market heatmap · StrategyVerse · Quant Research · WOBR.AI